Diazepam and nordiazepam in plasma: Liquid-liquid and solid phase extraction in sample pretreatment for high performance liquid chromatography analysis.

被引:6
作者
Freire, EF [1 ]
Miranda, JL [1 ]
Maia, PP [1 ]
Vieira, EP [1 ]
Borges, KB [1 ]
de Siqueira, MEPB [1 ]
机构
[1] Ctr Univ Fed, Escola Farm & Odontol Alfenas, Dept Anal Clin & Toxicol, BR-37130000 Alfenas, MG, Brazil
来源
QUIMICA NOVA | 2005年 / 28卷 / 05期
关键词
diazepam; nordiazepam; plasma extraction;
D O I
10.1590/S0100-40422005000500007
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Analysis of diazepam (DZP) and its active metabolite nordiazepam (NDZP) in plasma is commonly performed in clinical medicine to ensure proper therapeutic effects while minimizing the incidence of toxicity. This study aimed to optimize analytical parameters and compare two pre-treatment techniques, liquid-liquid (LLE) and solid phase extraction (SPE), as well as liquid chromatographic conditions to analyze simultaneously DZP and NDZP in plasma from 20 patients treated with a daily dose of 10 mg. Both techniques showed to be well in line with the international criteria for analytical validation, which permitted to quantify DZP (66.2 - 1148.6 ng mL(-1)) and NDZP (138.5 - 808.6 ng mL(-1)) in all samples. The correlation coefficients between SPE and LLE were respectively 0.9729 for DZP and 0.9643 for NDZP.
引用
收藏
页码:773 / 776
页数:4
相关论文
共 21 条
[1]  
Ahrens B, 2000, ARZNEIMITTEL-FORSCH, V50, P1057
[2]   SOLID-PHASE MICROEXTRACTION WITH THERMAL-DESORPTION USING FUSED-SILICA OPTICAL FIBERS [J].
ARTHUR, CL ;
PAWLISZYN, J .
ANALYTICAL CHEMISTRY, 1990, 62 (19) :2145-2148
[3]   Rapid and simple chromatographic method for the determination of diazepam and its major metabolites in human plasma and urine [J].
Azzam, RM ;
Notarianni, LJ ;
Ali, HM .
JOURNAL OF CHROMATOGRAPHY B, 1998, 708 (1-2) :304-309
[4]  
BALDESSARNI RJ, 2001, GOODMAN GILMANS PHAR, pCH19
[5]   PLASMA-LEVEL OF DIAZEPAM AS A THERAPEUTIC PREDICTOR IN ANXIETY-STATES [J].
BIANCHI, GN ;
FENNESSY, MR ;
PHILLIPS, J ;
EVERITT, BS .
PSYCHOPHARMACOLOGIA, 1974, 35 (02) :113-122
[6]  
Chase HA, 1998, J MOL RECOGNIT, V11, P217, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<217::AID-JMR426>3.0.CO
[7]  
2-D
[8]   DEVELOPMENT AND PRELIMINARY APPLICATION OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY OF URINARY METABOLITES OF DIAZEPAM IN HUMANS [J].
CHIBA, K ;
HORII, H ;
CHIBA, T ;
KATO, Y ;
HIRANO, T ;
ISHIZAKI, T .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 668 (01) :77-84
[9]  
de Haro L, 2001, VET HUM TOXICOL, V43, P174
[10]   QUANTITATION BY GAS-CHROMATOGRAPHY WITH SELECTED-ION MONITORING MASS-SPECTROMETRY OF NATURAL DIAZEPAM, N-DESMETHYLDIAZEPAM AND OXAZEPAM IN NORMAL HUMAN SERUM [J].
DUTHEL, JM ;
CONSTANT, H ;
VALLON, JJ ;
ROCHET, T ;
MIACHON, S .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 579 (01) :85-91